41 reports

  • 6.2.5 Gastrointestinal Cancer Liquid Biopsy Market & Forecast
  • GLOBAL - GASTROINTESTINAL CANCER LIQUID BIOPSY MARKET (MILLION US$), 2015 - 2017

The global liquid biopsy market is expected to surpass US$ 5 Billion mark by 2025. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization...

  • Biopsy
  • World
  • Forecast
  • Market Size
  • MDxHealth SA

REST OF WORLD PART D: ANNEXURE ##.

  • Biopsy
  • Europe
  • United States
  • World
  • Market Shares

Gastrointestinal Cancer ##. ##. ##.

  • Biopsy
  • Diagnostics
  • World
  • Market Size

GLOBAL LIQUID BIOPSY MARKET FORECAST 2018-2026 ##.

  • Biopsy
  • Diagnostics
  • World
  • Market Size

GASTROINTESTINAL (GI) BIOPSY ##. ##. ##.

  • Biopsy
  • Diagnostics
  • World
  • 8.5.2 Product Portfolio
  • 9. Global Biopsy Device Market - Mergers and Acquisitions/Key Deals

Intended for one-time use. ##.

  • Biopsy
  • World
  • Forecast
  • Boston Scientific Corporation
  • Hologic, Inc.

Gastrointestinal and Gliomas are the other important type of cancer.

  • Biopsy
  • World
  • Market Size
  • Biocept, Inc.
  • Guardant Health, Inc.

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • Australasia
  • Australia
  • Oceania
  • Forecast
  • 9. Global Biopsy Device Market - Mergers and Acquisitions/Key Deals

These instruments are intended for endoscopic gastrointestinal biopsy and should not be used for any purpose other than their intended function.

  • Biopsy
  • Breast Cancer
  • World
  • Boston Scientific Corporation
  • Hologic, Inc.

GASTROINTESTINAL (GI) BIOPSY ##. ##. ##.

  • Biopsy
  • Diagnostic Imaging
  • Diagnostics
  • Europe

GASTROINTESTINAL (GI) BIOPSY ##. ##. ##.

  • Biopsy
  • Diagnostic Imaging
  • Diagnostics
  • North America

The market by type of procedure is also discussed, which includes trends and market estimates of key therapeutic areas such as breast cancer, gastrointestinal cancer, lung cancer and cervical cancer, among others.

  • Biopsy
  • Diagnostic Imaging
  • Diagnostics
  • World

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • Southern Europe
  • Spain
  • Forecast
  • Olympus Corporation

GASTROINTESTINAL (GI) BIOPSY ##. ##. ##.

  • Biopsy
  • Diagnostic Imaging
  • Diagnostics
  • APAC

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • Brazil
  • South America
  • Forecast
  • Medtronic, Inc.

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • Latin America
  • Mexico
  • North America
  • Forecast

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • China
  • East Asia
  • Forecast
  • Olympus Corporation

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • India
  • South Asia
  • Forecast
  • Olympus Corporation

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • Italy
  • Southern Europe
  • Forecast
  • Olympus Corporation

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • Eastern Europe
  • Russia
  • Forecast
  • Medtronic, Inc.

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • East Asia
  • South Korea
  • Forecast
  • Olympus Corporation

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • East Asia
  • Japan
  • Forecast
  • Olympus Corporation
  • SELECTED CTDNA-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT, 2017
  • GENOMIC HEALTH

THE PAN-CANCER PANEL TEST WILL DETECT MORE THAN ## SNV, INSERTIONS AND DELETIONS ON SEVEN ONCOGENES SPECIFIC TO LUNG, PANCREATIC, COLORECTAL, MELANOMA, AND GASTROINTESTINAL STROMAL TUMORS.

  • Biopsy
  • World
  • Epigenomics AG
  • QIAGEN N.V.
  • Roche Group

Excisional Biopsy ##.

  • Biopsy
  • United States
  • B. Braun Melsungen AG
  • Becton Property Group
  • Boston Scientific Corporation
  • 2.4 THE SITUATION TODAY - BIOPSY ANALYSIS
  • 4.46 CIRCULOGENE LIQUID BIOPSY DETECTS NEW TUMOR MASS EARLIER THAN CURRENT IMAGING METHODS

The double-balloon " push-pull" technique allows visualization and biopsy of the entire gastrointestinal tract.

  • Biopsy
  • United States
  • Market Size
  • Illumina, Inc.
  • Trovagene, Inc.
  • 2.4 THE SITUATION TODAY - BIOPSY ANALYSIS
  • 4.46 CIRCULOGENE LIQUID BIOPSY DETECTS NEW TUMOR MASS EARLIER THAN CURRENT IMAGING METHODS

The double-balloon " push-pull" technique allows visualization and biopsy of the entire gastrointestinal tract.

  • Biopsy
  • United States
  • Market Size
  • Illumina, Inc.
  • Trovagene, Inc.
  • We have been able to identify over 114 liquid biopsy tests in our database, of which
  • 5. MARKET LANDSCAPE

THE FIVE PROGRAMS INCLUDE LUNG CANCER, BREAST CANCER, PROSTATE CANCER, RENAL CANCER AND GASTROINTESTINAL CANCER.

  • Biopsy
  • North America
  • United States
  • Market Size
  • Biocept, Inc.
  • MULTIPLE CORE BIOPSY DEVICE - PRODUCT DESCRIPTION
  • INFORCE BIOPSY DEVICE - PRODUCT DESCRIPTION

Biopsy Devices - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Biopsy Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Biopsy Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products...

  • Biopsy
  • Clinical Trial
  • Hospital
  • Medical Device
  • GlobalData's company
  • OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • BIOPSY DEVICES UNDER 21 CFR 876.1075 WITH PRODUCT CODES

No. ##.

  • Biopsy
  • North America
  • United States
  • Forecast
  • Becton Property Group

During the second quarter of 2017, EDAP sold ## Focal One and ## Ablatherm HIFU devices compared to ## Focal One and ## Ablatherm devices during the second quarter of 2016.

  • Biopsy
  • Diagnostic Imaging
  • Ultrasound
  • United States
  • Company